Stifel Financial’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22M | Sell |
112,033
-989
| -0.9% | -$192K | 0.02% | 598 |
|
|
2025
Q4 | $19.6M | Buy |
113,022
+80
| +0.1% | +$14.6K | 0.02% | 636 |
|
|
2025
Q3 | $21.5M | Sell |
112,942
-2,722
| -2% | -$483K | 0.02% | 601 |
|
|
2025
Q2 | $20.8M | Sell |
115,664
-10,336
| -8% | -$1.8M | 0.02% | 573 |
|
|
2025
Q1 | $21.3M | Sell |
126,000
-85
| -0.1% | -$14K | 0.02% | 537 |
|
|
2024
Q4 | $19M | Buy |
126,085
+54,383
| +76% | +$8.46M | 0.02% | 589 |
|
|
2024
Q3 | $11.1M | Sell |
71,702
-2,206
| -3% | -$329K | 0.01% | 811 |
|
|
2024
Q2 | $10.1M | Sell |
73,908
-5,821
| -7% | -$797K | 0.01% | 812 |
|
|
2024
Q1 | $10.6M | Buy |
79,729
+9,680
| +14% | +$1.26M | 0.01% | 792 |
|
|
2023
Q4 | $9.66M | Sell |
70,049
-2,336
| -3% | -$307K | 0.01% | 781 |
|
|
2023
Q3 | $8.82M | Buy |
72,385
+4,280
| +6% | +$570K | 0.01% | 773 |
|
|
2023
Q2 | $9.57M | Sell |
68,105
-3,400
| -5% | -$469K | 0.01% | 734 |
|
|
2023
Q1 | $10.1M | Sell |
71,505
-51,799
| -42% | -$7.41M | 0.01% | 685 |
|
|
2022
Q4 | $19.3M | Sell |
123,304
-12,876
| -9% | -$1.85M | 0.03% | 458 |
|
|
2022
Q3 | $16.7M | Sell |
136,180
-180
| -0.1% | -$23.7K | 0.03% | 478 |
|
|
2022
Q2 | $18.1M | Sell |
136,360
-1,631
| -1% | -$222K | 0.03% | 472 |
|
|
2022
Q1 | $18.9M | Sell |
137,991
-1,095
| -0.8% | -$153K | 0.03% | 522 |
|
|
2021
Q4 | $24.1M | Sell |
139,086
-2,487
| -2% | -$378K | 0.03% | 446 |
|
|
2021
Q3 | $20.6M | Buy |
141,573
+3,581
| +3% | +$524K | 0.03% | 467 |
|
|
2021
Q2 | $18.2M | Buy |
137,992
+6,236
| +5% | +$816K | 0.03% | 495 |
|
|
2021
Q1 | $16.9M | Sell |
131,756
-2,024
| -2% | -$249K | 0.03% | 480 |
|
|
2020
Q4 | $15.9M | Sell |
133,780
-19,319
| -13% | -$2.36M | 0.03% | 462 |
|
|
2020
Q3 | $17.5M | Buy |
153,099
+61,173
| +67% | +$7.23M | 0.04% | 384 |
|
|
2020
Q2 | $10.5M | Sell |
91,926
-9,042
| -9% | -$959K | 0.02% | 491 |
|
|
2020
Q1 | $8.1M | Sell |
100,968
-10,877
| -10% | -$1.13M | 0.02% | 507 |
|
|
2019
Q4 | $12M | Buy |
111,845
+42,969
| +62% | +$4.48M | 0.02% | 541 |
|
|
2019
Q3 | $7.37M | Buy |
68,876
+1,702
| +3% | +$175K | 0.02% | 665 |
|
|
2019
Q2 | $6.84M | Sell |
67,174
-130,976
| -66% | -$12.6M | 0.02% | 722 |
|
|
2019
Q1 | $17.8M | Buy |
198,150
+16,105
| +9% | +$1.4M | 0.05% | 348 |
|
|
2018
Q4 | $15M | Buy |
182,045
+149,977
| +468% | +$14.1M | 0.05% | 354 |
|
|
2018
Q3 | $3.44M | Buy |
32,068
+4,067
| +15% | +$446K | 0.01% | 998 |
|
|
2018
Q2 | $3.07M | Sell |
28,001
-97,277
| -78% | -$10.1M | 0.01% | 1007 |
|
|
2018
Q1 | $12.6M | Buy |
125,278
+4,682
| +4% | +$480K | 0.04% | 447 |
|
|
2017
Q4 | $11.9M | Buy |
120,596
+67,367
| +127% | +$6.39M | 0.04% | 457 |
|
|
2017
Q3 | $4.98M | Buy |
53,229
+1,153
| +2% | +$122K | 0.02% | 735 |
|
|
2017
Q2 | $5.8M | Buy |
52,076
+1,547
| +3% | +$164K | 0.02% | 664 |
|
|
2017
Q1 | $4.97M | Sell |
50,529
-5,817
| -10% | -$555K | 0.02% | 695 |
|
|
2016
Q4 | $5.18M | Sell |
56,346
-1,278
| -2% | -$110K | 0.02% | 652 |
|
|
2016
Q3 | $4.86M | Sell |
57,624
-2,461
| -4% | -$207K | 0.02% | 646 |
|
|
2016
Q2 | $4.89M | Sell |
60,085
-16,639
| -22% | -$1.27M | 0.02% | 617 |
|
|
2016
Q1 | $5.48M | Buy |
76,724
+17,140
| +29% | +$1.15M | 0.03% | 506 |
|
|
2015
Q4 | $4.24M | Sell |
59,584
-1,603
| -3% | -$108K | 0.02% | 627 |
|
|
2015
Q3 | $3.76M | Buy |
61,187
+10,098
| +20% | +$706K | 0.02% | 626 |
|
|
2015
Q2 | $3.68M | Buy |
51,089
+13,561
| +36% | +$1M | 0.02% | 705 |
|
|
2015
Q1 | $2.88M | Buy |
37,528
+6,016
| +19% | +$431K | 0.02% | 791 |
|
|
2014
Q4 | $2.11M | Buy |
31,512
+18,251
| +138% | +$1.15M | 0.01% | 884 |
|
|
2014
Q3 | $805K | Sell |
13,261
-24,050
| -64% | -$1.48M | 0.01% | 1248 |
|
|
2014
Q2 | $2.19M | Buy |
37,311
+3,593
| +11% | +$210K | 0.02% | 742 |
|
|
2014
Q1 | $1.95M | Buy |
+33,718
| New | +$1.81M | 0.02% | 759 |
|
Other funds holding DGX
VCM
VPM
EIG
Stifel Financial's DGX Position: Q1 2026 in Review
Stifel Financial reduced its Quest Diagnostics (DGX) stake by 0.88% in Q1 2026, selling an estimated $192K and leaving 112,033 shares worth $22M. The position accounts for 0.02% of the portfolio, ranked #598.
Stifel Financial first reported a position in DGX in Q1 2014 and has held it in 49 quarters since. The position peaked at $24.1M in Q4 2021. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Stifel Financial held 112,033 shares of Quest Diagnostics worth $22M as of Q1 2026.
- Stifel Financial sold 989 Quest Diagnostics shares in Q1 2026, an estimated $192K.
- Quest Diagnostics made up 0.02% of Stifel Financial's portfolio in Q1 2026, its #598 holding.
- Stifel Financial first reported a position in Quest Diagnostics in Q1 2014 and has held it in 49 quarters since.
- Stifel Financial's Quest Diagnostics position peaked at $24.1M in Q4 2021.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.